Business Courses

qPCR and Next-Generation Sequencing (NGS): Market and Competitive Analysis

This Business Course is being held in Hamburg on the 05 June 2013 at 14:00-17:00

Price:

Enal Razvi Biotechnology Analyst, Select Biosciences

This Business Course Presents an Up-to-Date Market Analysis of the qPCR and Next Generation Sequencing (NGS) Spaces from the Following Perspectives:

1. Instrumentation Platforms for Research: qPCR and NGS
2. Reagent Kits for qPCR and NGS
3. Sample-Prep Automation
4. Informatics/Data Analysis
5. Collaborations and Partnerships

Also focused upon in this business course are the platform diagnostic tests based on qPCR and the emerging emphasis of clinic sequencing in oncology based on NGS of tumor samples.

The following specific data are presented in this business course:

1. Details of Instrumentation for qPCR
2. Details of Instrumentation for NGS
3. Reagents and Kits for qPCR
4. Reagents and Kits for NGS
5. Front-end Sample Preparation Kits
6. Diagnostics Tests based on RT-PCR
7. Clinical Applications of NGS in Oncology: Tumor Sequencing and Driver Mutations

All Business Course Delegates will Receive Electronic Copies of Materials Presented on CD will Full Commercial Rights to Use for R&D/Business Planning and Investor/Corporate Presentations.

Who Should Attend:

1. Vendors offering Products and Services in the qPCR, NGS Spaces
2. Companies Seeking to Enter these Markets with Novel Technologies
3. Academics and Licensing/Business Development Professionals